Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
112838301000001116 | Empagliflozin 10mg tablets 30 tablet (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
112838401000001112 | Empagliflozin 10mg tablets 30 tablet | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Jardiance 10mg tablets (Ethigen Ltd) 30 tablet | Is a | True | Empagliflozin 10mg tablets 30 tablet | Inferred relationship | Existential restriction modifier | |
Jardiance 10mg tablets (CST Pharma Ltd) 30 tablet | Is a | True | Empagliflozin 10mg tablets 30 tablet | Inferred relationship | Existential restriction modifier | |
Jardiance 10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet | Is a | True | Empagliflozin 10mg tablets 30 tablet | Inferred relationship | Existential restriction modifier | |
Jardiance 10mg tablets (DE Pharmaceuticals) 30 tablet | Is a | True | Empagliflozin 10mg tablets 30 tablet | Inferred relationship | Existential restriction modifier | |
Jardiance 10mg tablets (Originalis B.V.) 30 tablet | Is a | True | Empagliflozin 10mg tablets 30 tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets